-The Indian Express India is no insecure dictatorship junking international obligations for cheap populism. The highest court of the world's largest democracy has made a nuanced distinction between real innovation and marketing gimmickry. Yet, the Swiss pharmaceutical giant Novartis's response to the recent Supreme Court verdict in Novartis vs Union of India has been imperial in tone. The judgment "discourages innovative drug discovery", it claimed. It accused Indian law of lagging...
More »SEARCH RESULT
Total Matching Records found : 1516
Strangers turn saviours for this Lucknow baby
-The Times of India LUCKNOW: As a weaver at a small zardozi unit in Sheesh Mahal area, Aftab Husain barely managed to make Rs 100 per day. Already struggling to make ends meet, Husain got the shock of his life when doctors at King George Medical College, Lucknow, found that his newborn daughter was suffering from total anomalous pulmonary venous connection (TAPVC), a rare congenital heart ailment often referred to as...
More »Calling big pharma’s bluff -Dwijen Rangnekar
-The Hindu The lesson from the Supreme Court ruling on Gleevec is that pharmaceutical multinational corporations need to focus research on genuine innovations rather than on ways to evergreen their patents The much awaited Supreme Court judgment on Gleevec has been delivered. Novartis has failed in reversing the rejection of its patent. And, predictably - like a scratched record - there have been suggestions that pharma investments in India will dry...
More »Artful claims can’t decide patent law: court-J Venkatesan
-The Hindu The law of patent in India could not be developed on the artful drafting of claims by companies rather than on the intrinsic worth of invention, the Supreme Court has ruled, rejecting Novartis' claim for patent for its cancer drug. A Bench of Justices Aftab Alam and Ranjana Desai said, "We certainly do not wish the law of patent... to develop on the lines where there may be a vast...
More »Agent's apple growers don't get fruit of labour-Sandeep Pai
-DNA You may be cursing when you pay a high price for Kashmiri apples, wondering what share of the moneyorchard owners would receive. But in reality, the apple growers wouldn't be even knowing the price at which the fruit is sold in the mainland, leave alone reaping profits. Then, where does the money go? Into the pockets of commission agents, who, sitting in Delhi or any of the major cities, exploit and...
More »
